{"doi":"10.17615/6adk-r027","title":"Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib","abstract":"Dual human epidermal growth factor receptor 2 (HER2) targeting can increase pathologic complete response rates (pCRs) to neoadjuvant therapy and improve progression-free survival in metastatic disease. CALGB 40601 examined the impact of dual HER2 blockade consisting of trastuzumab and lapatinib added to paclitaxel, considering tumor and microenvironment molecular features.","journal":"UNC Libraries","year":2020,"id":137956,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9495,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":267506,"name":"Carey K. Anders","orcid":"0000-0001-9165-4074","position":1,"is_corresponding":false},{"id":1883,"name":"Charles M. Perou","orcid":"0000-0001-9827-2247","position":2,"is_corresponding":false},{"id":231713,"name":"Ian E. Krop","orcid":"0000-0002-6380-5944","position":3,"is_corresponding":false},{"id":396232,"name":"Constance Cirrincione","orcid":null,"position":4,"is_corresponding":false},{"id":491563,"name":"Brandelyn N. Pitcher","orcid":null,"position":5,"is_corresponding":false},{"id":249118,"name":"Lisa A. Carey","orcid":"0000-0003-2388-4649","position":6,"is_corresponding":false},{"id":598649,"name":"Michael D. Iglesia","orcid":"0000-0002-0841-2144","position":7,"is_corresponding":false},{"id":1870,"name":"Katherine A. Hoadley","orcid":"0000-0002-1216-477X","position":8,"is_corresponding":false},{"id":245477,"name":"Maggie C.U. Cheang","orcid":"0000-0001-5718-2501","position":9,"is_corresponding":false},{"id":374168,"name":"David W. Ollila","orcid":"0000-0003-4129-6808","position":10,"is_corresponding":false},{"id":599327,"name":"Douglas Weckstein","orcid":null,"position":11,"is_corresponding":false},{"id":598650,"name":"Baljit Singh","orcid":"0000-0002-7987-7336","position":12,"is_corresponding":false},{"id":230995,"name":"Donald A. Berry","orcid":"0000-0002-7657-3871","position":13,"is_corresponding":false},{"id":241722,"name":"Lyndsay N. Harris","orcid":"0000-0002-9774-6719","position":14,"is_corresponding":false},{"id":333273,"name":"William T. Barry","orcid":null,"position":15,"is_corresponding":false},{"id":420450,"name":"N. Lynn Henry","orcid":"0000-0002-4771-5930","position":16,"is_corresponding":false},{"id":3752,"name":"Eric P. Winer","orcid":"0000-0002-8819-1723","position":17,"is_corresponding":false},{"id":332489,"name":"Clifford A. Hudis","orcid":"0000-0001-7144-8791","position":0,"is_corresponding":true}],"reference_count":0,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-18T23:16:59.449905Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}